Breathless and Overlooked: How America's Emergency Rooms Are Missing Tuberculosis in Plain Sight

When Maria Delgado arrived at a Phoenix emergency department in the autumn of 2022, she had already visited two other ERs in the preceding six weeks. She presented each time with a persistent cough, night sweats, and an unexplained weight loss of eleven pounds. She was given antibiotics for suspected community-acquired pneumonia, told to rest, and discharged. On her third visit, a respiratory therapist noticed something in her chest X-ray that did not fit the pneumonia narrative. A subsequent sputum test confirmed active pulmonary tuberculosis. By that point, Delgado had been symptomatic—and contagious—for nearly three months.

Her story is not an anomaly. It is, according to infectious disease specialists and emergency medicine physicians interviewed for this investigation, a quiet pattern repeating itself in hospitals from New York to Los Angeles.

A Disease That Disguises Itself Well

Tuberculosis is, in clinical terms, a masterful impersonator. The bacterium Mycobacterium tuberculosis produces symptoms—chronic cough, hemoptysis, fever, fatigue, pleuritic chest pain—that overlap extensively with conditions emergency physicians encounter dozens of times each shift: pneumonia, bronchitis, lung cancer, and even congestive heart failure. In a setting defined by speed, triage scores, and throughput metrics, TB's slow, insidious presentation rarely triggers the same urgency as a myocardial infarction or a stroke.

"When someone comes in with chest pain, my first thought is cardiac," explained one emergency physician practicing at a large urban hospital in Chicago, who requested anonymity to speak candidly about institutional protocols. "TB is somewhere much further down the differential, and unless there's an obvious epidemiological flag—recent immigration, known exposure, homelessness—it often stays there."

That cognitive hierarchy has consequences. The Centers for Disease Control and Prevention reported 8,300 TB cases in the United States in 2022, a figure that public health experts widely acknowledge represents significant undercounting due to diagnostic delays and missed detections. Emergency departments, which serve as the primary point of healthcare contact for millions of uninsured and underinsured Americans, are frequently the only medical setting where high-risk individuals appear.

The Protocol Problem

Unlike hospitals in high-burden countries, American emergency departments operate without standardized, nationally mandated tuberculosis screening protocols. The decision to test for TB—whether through a chest X-ray review, sputum culture, or a nucleic acid amplification test—is largely left to the discretion of individual clinicians or the informal culture of a given institution.

The Joint Commission, which accredits more than 22,000 healthcare organizations in the United States, does not require emergency departments to implement TB-specific screening algorithms for symptomatic patients. The CDC's guidelines for TB elimination, while comprehensive, are directed primarily at public health departments and outpatient settings rather than emergency medicine workflows.

Dr. Lawrence Osei, an epidemiologist who has studied TB transmission in urban healthcare environments, argues that this regulatory gap is not incidental. "Emergency medicine has evolved to prioritize the immediately life-threatening," he said. "TB does not announce itself as immediately life-threatening in most presentations. So it gets managed as something else, and the window for early isolation and treatment closes."

The isolation question is particularly significant. Patients with active pulmonary TB who are not identified as such are not placed in negative-pressure airborne infection isolation rooms. They sit in waiting areas. They are treated in standard bays. The healthcare workers, other patients, and family members in proximity to them are exposed without any protective measures in place.

High-Volume, Low-Index: The ER Calculus

Emergency department overcrowding compounds the problem. The American College of Emergency Physicians has documented consistent capacity crises at hospitals nationwide, with boarding times and patient volumes reaching levels that leave physicians managing fifteen or more patients simultaneously during peak hours. In that environment, ordering a TB sputum culture—which requires patient cooperation, specific collection protocols, and results that will not return for days—feels clinically impractical.

"We're a rule-out-and-discharge culture," acknowledged a nurse practitioner working in a Houston-area ER with a significant immigrant patient population. "If the chest X-ray looks like pneumonia and the patient doesn't have any red flags, we treat for pneumonia. We're not set up to think longitudinally about what this patient's cough might mean three weeks from now."

Rapid molecular diagnostic tools, including GeneXpert MTB/RIF assays capable of detecting TB DNA within two hours, exist and are endorsed by the World Health Organization. Their adoption in American emergency departments, however, remains limited. Cost, reimbursement structures, and the absence of procurement mandates have kept these technologies largely confined to public health laboratories rather than bedside clinical settings.

Who Bears the Cost

The populations most affected by this diagnostic gap are also among the most medically vulnerable. Foreign-born individuals—who account for approximately 70 percent of all TB cases reported in the United States—often access care almost exclusively through emergency departments due to lack of insurance, language barriers, or immigration-related fears about engaging with the healthcare system. Individuals experiencing homelessness, incarcerated or recently released individuals, and those living with HIV or diabetes face similarly elevated TB risk and similarly diminished access to primary care.

For these populations, an emergency department visit represents not just an acute care moment but frequently the only opportunity a healthcare system will have to identify and interrupt an active TB infection. Missing that moment does not simply delay a diagnosis. It allows transmission to continue within communities that are already medically underserved and structurally vulnerable.

Delgado, reflecting on her three-month diagnostic odyssey, put it plainly: "I kept going back because I knew something was wrong. But each time, they found something that fit what they were looking for. Nobody was looking for TB."

Toward a Systemic Response

Several emergency medicine researchers and infectious disease advocates are calling for a tiered, risk-stratified TB screening framework specifically designed for ER settings. Such a protocol would prompt clinicians to consider TB when patients present with respiratory symptoms alongside identifiable risk factors, automatically triggering airborne precautions and rapid diagnostic testing before a working diagnosis is finalized.

Pilot programs in a small number of safety-net hospitals in California and New York have demonstrated that integrating TB screening prompts into electronic health record triage workflows can increase testing rates without significantly lengthening patient stays. Preliminary data from these initiatives suggest that early identification in emergency settings could reduce both treatment delays and secondary transmission events.

Advocates at the national level, including organizations aligned with the Stop TB Partnership's US elimination agenda, have begun pressing the CDC and the Centers for Medicare and Medicaid Services to consider emergency department TB screening as a quality metric tied to hospital reimbursement—a move that could create the institutional incentive structure currently missing from the landscape.

The argument, ultimately, is not complicated. Tuberculosis remains a curable disease. Every missed diagnosis is not merely a clinical error; it is a preventable extension of transmission, a preventable worsening of illness, and a preventable cost—measured in hospitalizations, public health interventions, and human lives—absorbed disproportionately by the communities least equipped to bear it.

America's emergency rooms are, for many of its highest-risk residents, the front line of tuberculosis detection. Right now, that front line has no protocol, no standard, and no mandate. That is not a clinical oversight. It is a public health failure demanding urgent correction.